Koyfin Home > Directory > Health Care > Amag Pharmaceuticals > Cost of Goods Sold

Amag Pharmaceuticals Cost of Goods Sold Chart (AMAG)

Amag Pharmaceuticals annual/quarterly Cost of Goods Sold from 2010 to 2020.
  • Amag Pharmaceuticals Cost of Goods Sold for the quarter ending June 06, 2020 was $26m a -17.97% decrease of -5m year over year
  • Amag Pharmaceuticals Cost of Goods Sold for the last 12 months ending June 06, 2020 was $139m a 1.71% increase of 2m year over year
  • Amag Pharmaceuticals Annual Cost of Goods Sold for 2019 was $149m a -63.79% decrease of -95m from 2018
  • Amag Pharmaceuticals Annual Cost of Goods Sold for 2018 was $244m a 28.17% increase of 69m from 2017
  • Amag Pharmaceuticals Annual Cost of Goods Sold for 2017 was $175m a 16.34% increase of 29m from 2016
Other Income Statement Metrics:
  • Amag Pharmaceuticals EBITDA for the quarter ending December 12, 2018 was $0m a -35,031.33% decrease of -29m year over year
  • Amag Pharmaceuticals Net Income for the quarter ending December 12, 2018 was $-22m a -143.49% increase of 32m year over year
  • Amag Pharmaceuticals Total Revenue for the quarter ending September 09, 2018 was $122m a -29.53% decrease of -36m year over year
View Chart On Koyfin

Quarterly AMAG Cost of Goods Sold Data

06/2020$26m
03/2020$35m
12/2019$57m
09/2019$31m
06/2019$34m
03/2019$31m
12/2018$35m
09/2018$53m
06/2018$88m
03/2018$71m

Annual AMAG Cost of Goods Sold Data

2019$149m
2018$244m
2017$175m
2016$146m
2015$117m
2014$32m
2013$21m
2012$31m
2011$51m
2010$43m